Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 20 studies | 47% ± 20% | |
brain | 17 studies | 39% ± 14% | |
peripheral blood | 15 studies | 29% ± 12% | |
intestine | 12 studies | 41% ± 25% | |
eye | 12 studies | 46% ± 19% | |
kidney | 10 studies | 45% ± 17% | |
liver | 7 studies | 39% ± 25% | |
heart | 6 studies | 29% ± 10% | |
pancreas | 5 studies | 66% ± 30% | |
bone marrow | 5 studies | 33% ± 17% | |
uterus | 5 studies | 59% ± 21% | |
prostate | 5 studies | 46% ± 21% | |
lymph node | 5 studies | 36% ± 17% | |
placenta | 4 studies | 68% ± 30% | |
esophagus | 4 studies | 46% ± 30% | |
breast | 4 studies | 56% ± 12% | |
adipose | 4 studies | 30% ± 5% | |
adrenal gland | 3 studies | 36% ± 11% | |
skin | 3 studies | 47% ± 13% | |
thymus | 3 studies | 60% ± 26% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 41111.09 | 2642 / 2642 | 100% | 1058.13 | 705 / 705 |
intestine | 100% | 14605.32 | 966 / 966 | 100% | 425.21 | 527 / 527 |
prostate | 100% | 16146.15 | 245 / 245 | 100% | 533.12 | 502 / 502 |
thymus | 100% | 20309.99 | 653 / 653 | 100% | 538.87 | 605 / 605 |
uterus | 100% | 15949.81 | 170 / 170 | 100% | 513.28 | 459 / 459 |
esophagus | 100% | 16181.35 | 1444 / 1445 | 100% | 370.74 | 183 / 183 |
kidney | 100% | 19323.46 | 89 / 89 | 100% | 454.93 | 899 / 901 |
ovary | 100% | 16881.83 | 180 / 180 | 100% | 502.80 | 429 / 430 |
breast | 100% | 20148.48 | 459 / 459 | 100% | 526.23 | 1115 / 1118 |
stomach | 100% | 11519.48 | 359 / 359 | 100% | 355.65 | 285 / 286 |
skin | 100% | 22947.90 | 1808 / 1809 | 100% | 469.78 | 470 / 472 |
lung | 100% | 18380.63 | 576 / 578 | 100% | 426.36 | 1151 / 1155 |
bladder | 100% | 14027.52 | 21 / 21 | 99% | 459.89 | 500 / 504 |
adrenal gland | 100% | 21238.25 | 258 / 258 | 99% | 353.41 | 228 / 230 |
pancreas | 98% | 9871.41 | 323 / 328 | 100% | 317.36 | 178 / 178 |
liver | 97% | 10012.69 | 220 / 226 | 96% | 206.41 | 391 / 406 |
adipose | 100% | 20145.20 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 369.54 | 29 / 29 |
muscle | 100% | 29491.44 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 11102.61 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 498.53 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 195.12 | 1 / 1 |
blood vessel | 99% | 12151.34 | 1327 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 392.57 | 79 / 80 |
heart | 97% | 17141.69 | 831 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 71% | 9357.68 | 658 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0051480 | Biological process | regulation of cytosolic calcium ion concentration |
GO_0021766 | Biological process | hippocampus development |
GO_0034605 | Biological process | cellular response to heat |
GO_0000165 | Biological process | MAPK cascade |
GO_0007165 | Biological process | signal transduction |
GO_1902309 | Biological process | negative regulation of peptidyl-serine dephosphorylation |
GO_0046827 | Biological process | positive regulation of protein export from nucleus |
GO_0001764 | Biological process | neuron migration |
GO_1901016 | Biological process | regulation of potassium ion transmembrane transporter activity |
GO_0086013 | Biological process | membrane repolarization during cardiac muscle cell action potential |
GO_0006605 | Biological process | protein targeting |
GO_0070972 | Biological process | protein localization to endoplasmic reticulum |
GO_0060306 | Biological process | regulation of membrane repolarization |
GO_0035332 | Biological process | positive regulation of hippo signaling |
GO_0051220 | Biological process | cytoplasmic sequestering of protein |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0003064 | Biological process | regulation of heart rate by hormone |
GO_0034504 | Biological process | protein localization to nucleus |
GO_0007346 | Biological process | regulation of mitotic cell cycle |
GO_0086091 | Biological process | regulation of heart rate by cardiac conduction |
GO_0021762 | Biological process | substantia nigra development |
GO_0034122 | Biological process | negative regulation of toll-like receptor signaling pathway |
GO_0008104 | Biological process | protein localization |
GO_0021987 | Biological process | cerebral cortex development |
GO_1905913 | Biological process | negative regulation of calcium ion export across plasma membrane |
GO_0002753 | Biological process | cytoplasmic pattern recognition receptor signaling pathway |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0031966 | Cellular component | mitochondrial membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005925 | Cellular component | focal adhesion |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0042470 | Cellular component | melanosome |
GO_0005634 | Cellular component | nucleus |
GO_0019899 | Molecular function | enzyme binding |
GO_0019904 | Molecular function | protein domain specific binding |
GO_0019903 | Molecular function | protein phosphatase binding |
GO_0045296 | Molecular function | cadherin binding |
GO_0005246 | Molecular function | calcium channel regulator activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0097110 | Molecular function | scaffold protein binding |
GO_0035591 | Molecular function | signaling adaptor activity |
GO_0015459 | Molecular function | potassium channel regulator activity |
GO_0044325 | Molecular function | transmembrane transporter binding |
GO_0003723 | Molecular function | RNA binding |
GO_0019855 | Molecular function | calcium channel inhibitor activity |
GO_0046982 | Molecular function | protein heterodimerization activity |
GO_0023026 | Molecular function | MHC class II protein complex binding |
GO_0140311 | Molecular function | protein sequestering activity |
GO_0051219 | Molecular function | phosphoprotein binding |
GO_0050815 | Molecular function | phosphoserine residue binding |
GO_0005515 | Molecular function | protein binding |
GO_0042826 | Molecular function | histone deacetylase binding |
Gene name | YWHAE |
Protein name | 14-3-3 protein epsilon 14-3-3 protein epsilon (Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon) 14-3-3 protein epsilon (14-3-3E) |
Synonyms | |
Description | FUNCTION: Adapter protein implicated in the regulation of a large spectrum of both general and specialized signaling pathways. Binds to a large number of partners, usually by recognition of a phosphoserine or phosphothreonine motif . Binding generally results in the modulation of the activity of the binding partner (By similarity). Positively regulates phosphorylated protein HSF1 nuclear export to the cytoplasm . Plays a positive role in the antiviral signaling pathway upstream of TBK1 via interaction with RIGI . Mechanistically, directs RIGI redistribution from the cytosol to mitochondrial associated membranes where it mediates MAVS-dependent innate immune signaling during viral infection . Plays a role in proliferation inhibition and cell cycle arrest by exporting HNRNPC from the nucleus to the cytoplasm to be degraded by ubiquitination . . |
Accessions | ENST00000575977.1 ENST00000573196.5 ENST00000571732.5 [P62258-2] ENST00000616643.3 [P62258-2] P62258 ENST00000466227.6 ENST00000573026.1 ENST00000627231.2 [P62258-1] ENST00000496706.1 B4DJF2 I3L3T1 I3L0W5 ENST00000626999.1 ENST00000264335.13 [P62258-1] K7EIT4 K7EM20 ENST00000628106.1 ENST00000629090.2 ENST00000628059.1 ENST00000630606.2 |